Please login to the form below

Not currently logged in
Email:
Password:

ThermiGen appoints Vladimir Paul-Blanc as president

He will also serve as the Almirall-owned firm's general manager

Vladimir_Paul-BlancMedical aesthetics technology firm ThermiGen has appointed Vladmir Paul-Blanc as its president and general manager.

Paul-Blanc’s new role at the firm, which was acquired by Spanish pharma company Almirall in 2016, will see him focus on driving short and long term revenues and goals through global operations, marketing, sales and coordination of business development activities.

He previously served Solta Medical - the aesthetics energy device division of Valeant Pharmaceuticals – as its general manager.

He said: “I couldn’t be more excitied to join Almirall and work with the Thermi organisation.

“The entire leadership team has done an extremely impressive job establishing Thermi products in the aesthetic energy-based devises category.

“I look forward to joining the team immediately and contributing to future growth and success.”

Paul-Blanc succeeds both Thermi’s previous CEO Paul Herchman and Kevin O’Brien, Thermi’s previous president, who move on to new roles as global strategic advisors to the Thermi board.

24th April 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics